New Method for Early Stage Breast Cancer Detection

Información del proyecto

MAMSCAN

Identificador del acuerdo de subvención: 836843

DOI

10.3030/836843

Proyecto cerrado

Fecha de la firma de la CE 21 Diciembre 2018

Fecha de inicio 1 Enero 2019

Fecha de finalización 30 Junio 2019

Financiado con arreglo a

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Coste total

€ 71 429,00

Aportación de la UE

€ 50 000,00

Coordinado por

IMAQEN OY
Finland

Periodic Reporting for period 1 - MAMSCAN (New Method for Early Stage Breast Cancer Detection)

Período documentado: 2019-01-01 hasta 2019-06-30

Resumen del contexto y de los objetivos generales del proyecto

Our breast imaging solution is responding to the pressing needs of the healthcare sector when the incidence of breast cancer is increasing and expenditure growing along with the ageing population and expanding western lifestyle.

Our goal is to offer a device for cost-efficient, non-invasive and accurate breast check, which could be easily performed e.g. part of yearly general health exams or gynaecological visits. Near 50% of the breast cancers are detected outside the screening programs. Our method utilizes a patented infrared-wavelength scanning method, which looking for suspect time-variant patterns caused by abnormal tumour vasculature. See figure 1 for socio-economic factors of breast cancer in EU.

Trabajo realizado desde el comienzo del proyecto hasta el final del período abarcado por el informe y los principales resultados hasta la fecha

During the Horizon phase 1 we have been actively following and deepened our knowledge especially on and clinical requirements, market development and emerging technologies of breast imaging. We have opened doors to clinical test sites in order to collect clinical material needed for verifying our mathematical analysis algorithms, and for implementation of machine learning tools. We’ve been actively following the breast imaging market and technology development through publication reviews, market studies and commercial exhibition visit. We will continue with our original business plan but expect the launch to be delayed from the original plan. We will also be looking for possibilities to utilize our technology in other medical applications.

Avances que van más allá del estado de la técnica e impacto potencial esperado (incluida la repercusión socioeconómica y las implicaciones sociales más amplias del proyecto hasta la fecha)

We will go forward with the original business plan but expect it to take longer time than foreseen due to delays in starting longer-term clinical testing. By expanding the possibilities for women to check their breasts more often than easier, would have substantial favorable impact to socio-economic factors described in the figure 1.

socio-economic-factors-of-breast-cancer-in-eu.jpg